Cramer’s lightning round: Stay long on CF Industries

Cramer’s lightning round: Stay long on CF Industries


ON Semiconductor Corp: “Right now, I’ve got a pause on the semis. Why? Because we’ve got so many problems right now in China.”

Dutch Bros Inc: “I want you to put half the position on now, and then half when it goes below $30. … I like the stock, though.”

NIO Inc: “I have to say no to that. … I think that that stock is not a buy.”

Cinemark Holdings Inc: “This is a very difficult business. … I’m going to have to say, once again, [don’t buy.]”

Cano Health Inc: “I like the healthcare space, I think they do quality healthcare work, and I’m going to have to say that I think it’s worth buying.”

Uranium Energy Corp: “There’s been no real sign that we’re going back to nuclear. … I have to say, [don’t buy].”

Cramer's lightning round: Stay long on CF Industries

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Business class+? Delta says segmentation is coming to high-end cabins
Business

Business class+? Delta says segmentation is coming to high-end cabins

Nurphoto | Nurphoto | Getty Images Delta Air Lines is studying new types of airplane tickets — this time in the premium cabins at the front of the plane. Airlines spent years slicing up their coach cabins, from extra legroom seats to bare-bones basic economy fares that don’t allow changes or include a seat assignment. […]

Read More
Trump’s tariffs on Brazil could make your coffee even more expensive
Business

Trump’s tariffs on Brazil could make your coffee even more expensive

President Donald Trump’s proposed 50% tariff on Brazilian imports is bad news for coffee drinkers. Brazil, the largest U.S. supplier of green coffee beans, accounts for about a third of the country’s total supply, according to data from the U.S. Department of Agriculture. Coffee beans need to grow in a warm, tropical climate, making Hawaii […]

Read More
Space startup Varda raises 7 million in funding to make drugs in orbit
Business

Space startup Varda raises $187 million in funding to make drugs in orbit

Pavlo Gonchar | Lightrocket | Getty Images Space startup Varda announced on Thursday that it has raised $187 million in Series C funding, led by venture capital firms Natural Capital and Shrug Capital, to continue advancing drug manufacturing in space. The latest round included participation from Peter Thiel, Lux Capital, Khosla Ventures and Caffeinated Capital. […]

Read More